Home
Dashboard
About ONE
Curated content
Guide
Companies
Investors
More organizations
Job board
Transactions
Stats & Insights
Matching tool
Companies
Engrail Therapeutics
Save
Engrail Therapeutics
Acquiring, developing and commercializing transformative medicines.
Launch date
2019
Employees
11-50 people
Market cap
-
Enterprise valuation
€571—856m
(Dealroom.co estimates Mar 2024.)
San Diego California (HQ)
https://engrail.com/
https://www.linkedin.com/company/engrail-therapeutics/
B2B
manufacturing
health
biotechnology
pharmaceutical
hard tech
biotechnology
biotech and pharma
j&j request
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
Engrail Therapeutics funding
Engrail Therapeutics investors
Edit
Date
Investors
Amount
Round
Jun 2020
Nan Fung Life Sciences Real Estate
Nan Fung Life Sciences
$32.0m
Series A
Aug 2021
Nan Fung Life Sciences Real Estate
Nan Fung Life Sciences
$32.0m
Series A
Mar 2024
*
Eight Roads Ventures
Ysios Capital
Forbion Capital Partners
Norwest Venture Partners
Longwood Fund
RiverVest Venture Partners
F-Prime
Pivotal Life Sciences
Red Tree Venture Capital
$157m
Series B
Total Funding
€201m
Recent News about Engrail Therapeutics
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access
Investments by Engrail Therapeutics
Edit
Neurocycle Therapeutics
ACQUISITION by Engrail Therapeutics Feb 2021